Literature DB >> 32446162

Influence of stiripentol on perampanel serum levels.

Nicole Trabs1, Mathias Trabs2, Stefan Stodieck1, Patrick M House3.   

Abstract

Stiripentol is an orphan drug successfully used in combination with valproate and clobazam in the treatment of Dravet syndrome. Perampanel has also been added by experts. In this retrospective study, we investigated the influence of stiripentol on perampanel serum levels by using the doses and corresponding perampanel serum levels of 10 patients. The impact of stiripentol on the perampanel serum levels was significant as shown in a linear regression analysis, with perampanel serum levels increasing linearly with the stiripentol doses. We conclude that dose adjustments of stiripentol and perampanel when administered together, should be done carefully to avoid side effects or even severe intoxication. Hence, perampanel serum level monitoring seems advisable.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dravet syndrome; Perampanel; SMEI; Severe myoclonic epilepsy of infancy; Stiripentol

Year:  2020        PMID: 32446162     DOI: 10.1016/j.eplepsyres.2020.106367

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  1 in total

1.  Stiripentol Enteric Solid Dispersion-Loaded Effervescent Tablets: Enhanced Dissolution, Stability, and Absorption.

Authors:  Ying Wang; Siyuan Xu; Ziyue Xiao; Yuxin Jiang; Qi Jiang; Jun Li; Wei He
Journal:  AAPS PharmSciTech       Date:  2022-05-10       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.